BACKGROUND: Neurodegeneration with brain iron accumulation (NBIA) defines a group of genetic disorders characterized by brain iron deposition and associated with neuronal death. The known causes of NBIA include pantothenate kinase-associated neurodegeneration (PKAN), neuroferritinopathy, infantile neuroaxonal dystrophy (INAD), and aceruloplasminemia. OBJECTIVE: To define the radiologic features of each NBIA subtype. METHODS: Brain MRIs from patients with molecularly confirmed PKAN (26 cases), neuroferritinopathy (21 cases), INAD (four cases), and aceruloplasminemia (10 cases) were analyzed blindly to delineate patterns of iron deposition and neurodegeneration. RESULTS: In most cases of PKAN, abnormalities were restricted to globus pallidus and substantia nigra, with 100% having an eye of the tiger sign. In a minority of PKAN cases there was hypointensity of the dentate nuclei (1/5 on T2* sequences, 2/26 on fast spin echo [FSE]). In INAD, globus pallidus and substantia nigra were involved on T2* and FSE scans, with dentate involvement only seen on T2*. By contrast, neuroferritinopathy had consistent involvement of the dentate nuclei, globus pallidus, and putamen, with confluent areas of hyperintensity due to probable cavitation, involving the pallida and putamen in 52%, and a subset having lesions in caudate nuclei and thalami. More uniform involvement of all basal ganglia and the thalami was typical in aceruloplasminemia, but without cavitation. CONCLUSIONS: In the majority of cases, different subtypes of neurodegeneration associated with brain iron accumulation can be reliably distinguished with T2* and T2 fast spin echo brain MRI, leading to accurate clinical and subsequent molecular diagnosis.
BACKGROUND:Neurodegeneration with brain iron accumulation (NBIA) defines a group of genetic disorders characterized by brain iron deposition and associated with neuronal death. The known causes of NBIA include pantothenate kinase-associated neurodegeneration (PKAN), neuroferritinopathy, infantile neuroaxonal dystrophy (INAD), and aceruloplasminemia. OBJECTIVE: To define the radiologic features of each NBIA subtype. METHODS: Brain MRIs from patients with molecularly confirmed PKAN (26 cases), neuroferritinopathy (21 cases), INAD (four cases), and aceruloplasminemia (10 cases) were analyzed blindly to delineate patterns of iron deposition and neurodegeneration. RESULTS: In most cases of PKAN, abnormalities were restricted to globus pallidus and substantia nigra, with 100% having an eye of the tiger sign. In a minority of PKAN cases there was hypointensity of the dentate nuclei (1/5 on T2* sequences, 2/26 on fast spin echo [FSE]). In INAD, globus pallidus and substantia nigra were involved on T2* and FSE scans, with dentate involvement only seen on T2*. By contrast, neuroferritinopathy had consistent involvement of the dentate nuclei, globus pallidus, and putamen, with confluent areas of hyperintensity due to probable cavitation, involving the pallida and putamen in 52%, and a subset having lesions in caudate nuclei and thalami. More uniform involvement of all basal ganglia and the thalami was typical in aceruloplasminemia, but without cavitation. CONCLUSIONS: In the majority of cases, different subtypes of neurodegeneration associated with brain iron accumulation can be reliably distinguished with T2* and T2 fast spin echo brain MRI, leading to accurate clinical and subsequent molecular diagnosis.
Authors: Y Takeuchi; M Yoshikawa; T Tsujino; S Kohno; N Tsukamoto; A Shiroi; E Kikuchi; H Fukui; H Miyajima Journal: J Neurol Neurosurg Psychiatry Date: 2002-04 Impact factor: 10.154
Authors: Z Metafratzi; M I Argyropoulou; D N Kiortsis; C Tsampoulas; N Chaliassos; S C Efremidis Journal: Br J Radiol Date: 2001-05 Impact factor: 3.039
Authors: A R Curtis; C Fey; C M Morris; L A Bindoff; P G Ince; P F Chinnery; A Coulthard; M J Jackson; A P Jackson; D P McHale; D Hay; W A Barker; A F Markham; D Bates; A Curtis; J Burn Journal: Nat Genet Date: 2001-08 Impact factor: 38.330
Authors: M Daimon; S Susa; T Ohizumi; S Moriai; T Kawanami; A Hirata; H Yamaguchi; H Ohnuma; M Igarashi; T Kato Journal: Tohoku J Exp Med Date: 2000-07 Impact factor: 1.848
Authors: Martin Südmeyer; Andreas Saleh; Lars Wojtecki; Mathias Cohnen; Joachim Gross; Markus Ploner; Harald Hefter; Lars Timmermann; Alfons Schnitzler Journal: Mov Disord Date: 2006-12 Impact factor: 10.338
Authors: Michael J House; Timothy G St Pierre; Kris V Kowdley; Thomas Montine; James Connor; John Beard; Jose Berger; Narendra Siddaiah; Eric Shankland; Lee-Way Jin Journal: Magn Reson Med Date: 2007-01 Impact factor: 4.668
Authors: Sen Guo; Liu Yang; Huijie Liu; Wei Chen; Jinchen Li; Ping Yu; Zhong Sheng Sun; Xiang Chen; Jie Du; Tao Cai Journal: Mol Neurobiol Date: 2016-07-09 Impact factor: 5.590
Authors: Amit Batla; Matthew E Adams; Roberto Erro; Christos Ganos; Bettina Balint; Niccolo E Mencacci; Kailash P Bhatia Journal: Neurology Date: 2015-04-01 Impact factor: 9.910
Authors: David Devos; P Jissendi Tchofo; Isabelle Vuillaume; Alain Destée; Stephanie Batey; John Burn; Patrick F Chinnery Journal: Brain Date: 2008-10-14 Impact factor: 13.501